Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 9,584 shares at $36.39 ($348K) on 2023-10-05, disclosed to the SEC on 2023-10-06.
Open-market sale of $348k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.54 | 894 | $32K | 9.1% |
| 2 | $36.39 | 4,345 | $158K | 45.4% |
| 3 | $36.39 | 4,345 | $158K | 45.4% |
| Total | $36.31 avg | 9,584 | $348K | 100% |
| Filing → |
| IMVT | SELL | 2025-02-21 | $644K | — | Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |